Partnering

Collaboration is our Strength. We are committed to collectively growing the field of gene therapy and maximizing our impact through partnerships, collaborations and licensing. Apertura welcomes interest from pharma, biotech, rare disease advocacy organizations, N=1 families, and academia. Together, we can accelerate the development of transformative gene therapies for a broader range of patients.